Australian Clinical Labs Limited Announces Interim Dividend of $0.04 (ASX:ACL)

Australian Clinical Labs Limited (ASX:ACL) declared a interim dividend on Tuesday, February 17th, MarketIndexAU Dividends reports. Investors of record on Monday, March 30th will be given a dividend of 0.037 per share on Monday, March 30th. This represents a dividend yield of 170.0%. The ex-dividend date is Wednesday, March 11th.

Australian Clinical Labs Stock Performance

The company has a debt-to-equity ratio of 174.00, a current ratio of 0.64 and a quick ratio of 0.53. The firm has a market cap of $728.27 million, a PE ratio of 30.38, a price-to-earnings-growth ratio of -0.36 and a beta of 1.18.

About Australian Clinical Labs

Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services.